Table 3.
In-hospital outcomes
| All (n = 736) | VA group (n = 359) | Without VA group (n = 377) | P value | |
|---|---|---|---|---|
| In-hospital MACE, n (%) | 71 (9.6%) | 54 (15.0%) | 17 (4.5%) | < 0.001 |
| Cardiac death, n (%) | 17 (2.3%) | 14 (3.9%) | 3 (0.8%) | 0.005 |
| MI, n (%) | 58 (7.9%) | 48 (13.4%) | 10 (2.7%) | < 0.001 |
| TVR, n (%) | 42 (5.7%) | 33 (9.2%) | 9 (2.4%) | 0.001 |
| Acute stent thrombosis, n (%) | 6 (0.8%) | 3 (0.8%) | 3 (0.8%) | 0.998 |
Categorical variables were expressed as number (percentage)
VA Ventricular arrhythmia, MACE Major adverse cardiovascular event, TVR Target-vessel revascularization, MI Myocardial infarction